Logo image of AMEH

APOLLO MEDICAL HOLDINGS INC (AMEH) Stock Fundamental Analysis

NASDAQ:AMEH - Nasdaq - US03763A2078 - Common Stock - Currency: USD

40.82  -0.88 (-2.11%)

After market: 40.82 0 (0%)

Fundamental Rating

7

AMEH gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. AMEH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. AMEH is growing strongly while it is still valued neutral. This is a good combination! These ratings could make AMEH a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

AMEH had positive earnings in the past year.
In the past year AMEH had a positive cash flow from operations.
In the past 5 years AMEH has always been profitable.
Each year in the past 5 years AMEH had a positive operating cash flow.
AMEH Yearly Net Income VS EBIT VS OCF VS FCFAMEH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M 40M 60M 80M 100M

1.2 Ratios

With a decent Return On Assets value of 4.27%, AMEH is doing good in the industry, outperforming 74.58% of the companies in the same industry.
The Return On Equity of AMEH (7.71%) is better than 71.19% of its industry peers.
AMEH has a better Return On Invested Capital (7.06%) than 75.42% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AMEH is in line with the industry average of 9.55%.
Industry RankSector Rank
ROA 4.27%
ROE 7.71%
ROIC 7.06%
ROA(3y)6.13%
ROA(5y)4.48%
ROE(3y)12.25%
ROE(5y)10.02%
ROIC(3y)7.61%
ROIC(5y)7.78%
AMEH Yearly ROA, ROE, ROICAMEH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 500 1K 1.5K 2K

1.3 Margins

The Profit Margin of AMEH (3.45%) is better than 75.42% of its industry peers.
AMEH's Profit Margin has improved in the last couple of years.
AMEH's Operating Margin of 7.61% is fine compared to the rest of the industry. AMEH outperforms 77.97% of its industry peers.
In the last couple of years the Operating Margin of AMEH has grown nicely.
AMEH's Gross Margin of 16.34% is on the low side compared to the rest of the industry. AMEH is outperformed by 70.34% of its industry peers.
In the last couple of years the Gross Margin of AMEH has grown nicely.
Industry RankSector Rank
OM 7.61%
PM (TTM) 3.45%
GM 16.34%
OM growth 3Y14.1%
OM growth 5YN/A
PM growth 3Y19.41%
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y2.84%
AMEH Yearly Profit, Operating, Gross MarginsAMEH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20 -20 30

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AMEH is destroying value.
AMEH has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, AMEH has an improved debt to assets ratio.
AMEH Yearly Shares OutstandingAMEH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
AMEH Yearly Total Debt VS Total AssetsAMEH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M

2.2 Solvency

AMEH has an Altman-Z score of 4.53. This indicates that AMEH is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of AMEH (4.53) is better than 83.90% of its industry peers.
The Debt to FCF ratio of AMEH is 1.89, which is an excellent value as it means it would take AMEH, only 1.89 years of fcf income to pay off all of its debts.
AMEH's Debt to FCF ratio of 1.89 is amongst the best of the industry. AMEH outperforms 85.59% of its industry peers.
A Debt/Equity ratio of 0.35 indicates that AMEH is not too dependend on debt financing.
AMEH has a better Debt to Equity ratio (0.35) than 65.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.89
Altman-Z 4.53
ROIC/WACC0.85
WACC8.27%
AMEH Yearly LT Debt VS Equity VS FCFAMEH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 2.35 indicates that AMEH has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.35, AMEH is doing good in the industry, outperforming 79.66% of the companies in the same industry.
A Quick Ratio of 2.35 indicates that AMEH has no problem at all paying its short term obligations.
AMEH has a better Quick ratio (2.35) than 81.36% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.35
AMEH Yearly Current Assets VS Current LiabilitesAMEH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

8

3. Growth

3.1 Past

The earnings per share for AMEH have decreased strongly by -29.58% in the last year.
The Earnings Per Share has been growing by 42.03% on average over the past years. This is a very strong growth
AMEH shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.05%.
The Revenue has been growing by 81.94% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5YN/A
EPS Q2Q%-16.07%
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y81.94%
Sales Q2Q%9.84%

3.2 Future

The Earnings Per Share is expected to grow by 15.59% on average over the next years. This is quite good.
Based on estimates for the next years, AMEH will show a very strong growth in Revenue. The Revenue will grow by 26.59% on average per year.
EPS Next Y15.47%
EPS Next 2Y16.56%
EPS Next 3Y15.59%
EPS Next 5YN/A
Revenue Next Year25.04%
Revenue Next 2Y26.5%
Revenue Next 3Y26.59%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
AMEH Yearly Revenue VS EstimatesAMEH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
AMEH Yearly EPS VS EstimatesAMEH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 1 1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 40.82 indicates a quite expensive valuation of AMEH.
60.17% of the companies in the same industry are more expensive than AMEH, based on the Price/Earnings ratio.
AMEH's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.82.
Based on the Price/Forward Earnings ratio of 28.34, the valuation of AMEH can be described as expensive.
62.71% of the companies in the same industry are more expensive than AMEH, based on the Price/Forward Earnings ratio.
AMEH's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.21.
Industry RankSector Rank
PE 40.82
Fwd PE 28.34
AMEH Price Earnings VS Forward Price EarningsAMEH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMEH indicates a somewhat cheap valuation: AMEH is cheaper than 61.86% of the companies listed in the same industry.
73.73% of the companies in the same industry are more expensive than AMEH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.06
EV/EBITDA 15.55
AMEH Per share dataAMEH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
AMEH has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as AMEH's earnings are expected to grow with 15.59% in the coming years.
PEG (NY)2.64
PEG (5Y)N/A
EPS Next 2Y16.56%
EPS Next 3Y15.59%

More info and screens

0

5. Dividend

5.1 Amount

AMEH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

APOLLO MEDICAL HOLDINGS INC

NASDAQ:AMEH (2/23/2024, 8:00:00 PM)

After market: 40.82 0 (0%)

40.82

-0.88 (-2.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-07 2023-11-07/amc
Earnings (Next)02-27 2024-02-27/amc
Inst Owners53.14%
Inst Owner Change-1.43%
Ins Owners21.32%
Ins Owner Change0%
Market Cap1.90B
Analysts83.33
Price Target47.49 (16.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.31
Dividend Growth(5Y)N/A
DP7.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.72%
Min EPS beat(2)9.8%
Max EPS beat(2)39.63%
EPS beat(4)3
Avg EPS beat(4)20.8%
Min EPS beat(4)-0.9%
Max EPS beat(4)39.63%
EPS beat(8)6
Avg EPS beat(8)22.78%
EPS beat(12)10
Avg EPS beat(12)32.72%
EPS beat(16)12
Avg EPS beat(16)-118.74%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.17%
Revenue beat(4)2
Avg Revenue beat(4)4.65%
Min Revenue beat(4)-2.49%
Max Revenue beat(4)17.32%
Revenue beat(8)6
Avg Revenue beat(8)8.34%
Revenue beat(12)10
Avg Revenue beat(12)8.2%
Revenue beat(16)12
Avg Revenue beat(16)7.16%
PT rev (1m)4.22%
PT rev (3m)-6.25%
EPS NQ rev (1m)-0.44%
EPS NQ rev (3m)7.6%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.34%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.27%
Valuation
Industry RankSector Rank
PE 40.82
Fwd PE 28.34
P/S 1.43
P/FCF 17.06
P/OCF 14.21
P/B 3.2
P/tB 7.79
EV/EBITDA 15.55
EPS(TTM)1
EY2.45%
EPS(NY)1.44
Fwd EY3.53%
FCF(TTM)2.39
FCFY5.86%
OCF(TTM)2.87
OCFY7.04%
SpS28.49
BVpS12.74
TBVpS5.24
PEG (NY)2.64
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.27%
ROE 7.71%
ROCE 11.61%
ROIC 7.06%
ROICexc 10.35%
ROICexgc 25.21%
OM 7.61%
PM (TTM) 3.45%
GM 16.34%
FCFM 8.4%
ROA(3y)6.13%
ROA(5y)4.48%
ROE(3y)12.25%
ROE(5y)10.02%
ROIC(3y)7.61%
ROIC(5y)7.78%
ROICexc(3y)12.15%
ROICexc(5y)11.69%
ROICexgc(3y)43.38%
ROICexgc(5y)51.37%
ROCE(3y)12.51%
ROCE(5y)12.79%
ROICexcg growth 3Y1.89%
ROICexcg growth 5YN/A
ROICexc growth 3Y32.67%
ROICexc growth 5YN/A
OM growth 3Y14.1%
OM growth 5YN/A
PM growth 3Y19.41%
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y2.84%
F-Score6
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.89
Debt/EBITDA 1.76
Cap/Depr 132.23%
Cap/Sales 1.68%
Interest Coverage 8.45
Cash Conversion 113.54%
Profit Quality 243.47%
Current Ratio 2.35
Quick Ratio 2.35
Altman-Z 4.53
F-Score6
WACC8.27%
ROIC/WACC0.85
Cap/Depr(3y)82.27%
Cap/Depr(5y)51.68%
Cap/Sales(3y)1.55%
Cap/Sales(5y)1.01%
Profit Quality(3y)102.9%
Profit Quality(5y)124.71%
High Growth Momentum
Growth
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5YN/A
EPS Q2Q%-16.07%
EPS Next Y15.47%
EPS Next 2Y16.56%
EPS Next 3Y15.59%
EPS Next 5YN/A
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y81.94%
Sales Q2Q%9.84%
Revenue Next Year25.04%
Revenue Next 2Y26.5%
Revenue Next 3Y26.59%
Revenue Next 5YN/A
EBIT growth 1Y7.56%
EBIT growth 3Y44.74%
EBIT growth 5YN/A
EBIT Next Year55.45%
EBIT Next 3Y28.75%
EBIT Next 5YN/A
FCF growth 1Y77.28%
FCF growth 3Y67.35%
FCF growth 5YN/A
OCF growth 1Y67.48%
OCF growth 3Y81.79%
OCF growth 5YN/A